MOH — authorised 30 August 2005
- Marketing authorisation holder: IPSEN INC
- Status: likely_approved
MOH authorised Increlex on 30 August 2005
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 30 August 2005.
IPSEN INC holds the Israeli marketing authorisation.